CircuLating micrornas in post-COVID-19 patients and its association with cognitive impairment (opens in new tab)

Post-COVID-19 condition (PCC) develops after the acute phase of the SARS-CoV-2 infection with cognitive symptoms in 7.2-59.2% of cases, affecting primarily executive function, memory and attention-processing speed. MicroRNAs (miRNAs) are vital neurophysiological regulators and potential non-invasive biomarkers. This study analyzes a complete neuropsychological battery in 48 PCC patients, grouped into cognitively impaired (PCC-CI) and cognitively healthy (PCC-CH), and 16 controls; and quantifi...